Cargando…
Pretreatment with geniposide mitigates myocardial ischemia/reperfusion injury by modulating inflammatory response through tLr4/NF-κb pathway
Geniposide (GEN), a medical herb, is known for its therapeutic applications in cardiovascular diseases, though its efficacy in treating myocardial ischemia/reperfusion injury (MI/RI) is yet to be fully elucidated. This study is an endeavor to explore the potential protective mechanism of GEN against...
Autores principales: | Yao, Yanmei, Lin, Leqing, Tang, Wenxue, Shen, Yueliang, Chen, Fayu, Li, Ning, Wang, Baiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518652/ https://www.ncbi.nlm.nih.gov/pubmed/37682077 http://dx.doi.org/10.4081/ejh.2023.3742 |
Ejemplares similares
-
Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
por: Li, Haiyan, et al.
Publicado: (2022) -
Protective Effects of Geniposide and Genipin against Hepatic Ischemia/Reperfusion Injury in Mice
por: Kim, Joonki, et al.
Publicado: (2013) -
Pretreatment with Erythropoietin Attenuates Lung Ischemia/Reperfusion Injury via Toll-Like Receptor-4/Nuclear Factor-κB (TLR4/NF-κB) Pathway
por: He, Qian, et al.
Publicado: (2018) -
The effect of focal cerebral ischemia-reperfusion injury on TLR4 and NF-κB signaling pathway
por: Chen, Jing, et al.
Publicado: (2018) -
Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-κB Signaling Pathway
por: Sherif, Iman O., et al.
Publicado: (2018)